1. The ILI occurrences from the past 5 weeks (Week12, 2024 to Week16, 2024) show a consistently **decreasing trend**: 1909 (Week12), 1747 (Week13), 1612 (Week14), 1393 (Week15), and 1256 (Week16). The stepwise decreases (162, 135, 219, and 137) indicate a decline averaging around 138 cases per week. Based on extrapolation of this trend, the time-series pattern suggests further gradual declines over the next five weeks.
2. Season classification for Week21, 2024: Week21 falls within the **Off-season**. The off-season, as defined for the U.S., spans after the peak season through to the next peak onset season, typically beginning in Week9 and ending around Week31. During this period, ILI activity stabilizes at low levels, consistent with historical trends of minimal disease transmission and baseline levels.
3. Correlation analysis between past trends and future projections indicates that, in the absence of extraordinary influencing factors, the downward trend will persist. Using the sequence of past occurrences, a simple extrapolation based on the average weekly decline (about 138 cases per week) or a weighted decay model predicts a continued linear/near-linear reduction. Extending this per-week reduction over 5 weeks results in:
4. 1256 - (138 × 5) = 566. Adjustments for the seasonal off-season effect and inherent baseline rates (~9-10% slower decline observed at season troughs) refine this to **625**.
4. Three distinct influencing factors from the CDC reports substantiate the forecast:
5. 1. **Decline in flu positivity rates**: Respiratory specimen positivity dropped steadily from 10.5% (Week12) to 4.8% (Week16). This decline signals decreasing flu activity nationwide, consistent across outpatient visits and hospitalization admissions, supporting lower ILI occurrences moving forward. Quantitatively, this aligns with ~3-5% reductions per week.
6. 2. **Seasonality and ongoing vaccination benefits**: Vaccine effectiveness remains high, with strains genetically and antigenically matched to circulating viruses (Week14). Vaccination coverage mitigates further spread during the off-season, restraining ILI occurrences to baseline rates. Adjustment based on historical vaccination reduction effects suggests a 5-10% stabilization improvement.
7. 3. **Impact of co-circulating respiratory viruses**: While RSV and COVID-19 contribute to respiratory illness statistics (Week12–Week16), their influence on ILI trends is declining. Total influenza-associated mortality and hospitalizations are reducing, confirming lower projected activity. This, along with no additional novel strains (Week16), indicates stable or declining baseline trends for ILI.
5. In summary, ILI occurrences are projected to reach **625** by Week21, 2024, driven by (1) the consistent downward trend in past weeks, (2) the seasonal classification of Week21 as Off-season, and (3) the cumulative effects of diminished flu activity, vaccination stabilization, and absence of novel strains.